Eptifibatide is a platelet aggregation inhibitor used in the treatment of acute coronary syndrome and during percutaneous coronary interventions (PCI). It prevents the binding of fibrinogen to platelet receptors, reducing platelet aggregation and clot formation.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Eptifibatide and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Eptifibatide impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Eptifibatide-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.